Physician profile
Amy Cofer
NPI 1831173939
$925.20
in general payments reported to CMS, 2019-2025
16 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $146 · 2023: $163 · 2024: $119 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $148.60 | 2021-2025 | Veozah |
| Novo Nordisk INC | $118.69 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $95.32 | 2021-2025 | |
| Pfizer INC. | $90.22 | 2022-2025 | |
| Dexcom, INC. | $80.00 | 2023-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $78.39 | 2021-2025 | Minimed 780g |
| Glaxosmithkline, LLC. | $57.76 | 2024-2025 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $54.54 | 2021 | |
| Amgen INC. | $47.20 | 2024-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $42.38 | 2023-2025 | Airsupra, Farxiga |
| Smith+Nephew, INC. | $27.58 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.28 | 2025 | Jardiance |
| Abbott Laboratories | $17.31 | 2025 | Eterna |
| Merck Sharp & Dohme LLC | $17.08 | 2023 | Verquvo, Belsomra, Steglatro |
| Boston Scientific Corporation | $16.08 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Cofer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.